173 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
and hedging transactions Prohibition on pledging shares and holding them in a margin account Proactively eliminate windfall gain potential No employment … engaging in any speculative or hedging transactions, as we consider it improper and inappropriate to engage in any transactions that hedge or offset
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
, financial advisory, investment management, principal investment, hedging, financing and brokerage activities. For example, certain of the underwriters … as counterparties to certain derivative and hedging arrangements, and actively trade debt and equity securities (or related derivative securities
424B2
rgu93r4pphwob6es14g9
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
x9piyai1 ykaua73yyz
25 Jan 24
Third party tender offer statement
8:13am
424B5
ydn9fj6do5qwjqnfv
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
9pyz0cognkfdps0z7ip
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
efkoi 2u142xg70yhn79
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
rzyumepoid
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
xmpdorh8qb8dsio ez
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
edf5y
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
SC TO-T
EX-99
wywuow7pn2h4ihdl6
17 Jun 22
Third party tender offer statement
4:42pm